We are live on !
Find out more
Aviva Portfolio holdings
AUM
$67.9B
Turnover
14.13%
1-Year Est. Return
39.2%
This Fund
S&P 500
This Quarter Est. Return
+24.14%
1 Year Est. Return
+39.2%
3 Year Est. Return
+122.83%
5 Year Est. Return
+153.91%
10 Year Est. Return
+555.26%
AUM
$67.9B
AUM Growth
+$8.32B
(+14%)
Cap. Flow
+$277M
Cap. Flow % of AUM
Cap. Flow %
0.41%
Top 10 Holdings %
Top 10 Hldgs %
33.58%
Holding
913
New
70
Increased
471
Reduced
285
Closed
59
Avg Time Held
7.5
years
Top 10 Avg Time Held
5.9
years
Top 20 Avg Time Held
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$78M |
| 2 |
Advanced Micro Devices
AMD
|
+$73.8M |
| 3 |
Amazon
AMZN
|
+$70M |
| 4 |
Arista Networks
ANET
|
+$64.2M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$189M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$71.7M |
| 3 |
Abbott
ABT
|
+$70.1M |
| 4 |
Honeywell
HON
|
+$63.6M |
| 5 |
T-Mobile US
TMUS
|
+$56.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.43% |
| 2 | Financials | 12.37% |
| 3 | Healthcare | 11.32% |
| 4 | Communication Services | 9.15% |
| 5 | Consumer Discretionary | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Revolution Medicines
RVMD
$42.1B
| $22.1M | 0.03% |
118,070
+96,610
| +450% | +$14.1M |
2026 Q1
1 quarter
|
|
402
GE HealthCare
GEHC
$31.7B
| $22M | 0.03% |
343,551
+3,377
| +1% | +$222K |
2023 Q1
13 quarters
|
|
403
Illumina
ILMN
$40.5B
| $21.9M | 0.03% |
124,644
-8,582
| -6% | -$1.26M |
2013 Q2
52 quarters
|
|
404
Copart
CPRT
$25.8B
| $21.8M | 0.03% |
774,255
+719
| +0.1% | +$23.2K |
2018 Q3
31 quarters
|
|
405
Willis Towers Watson
WTW
$29.6B
| $21.7M | 0.03% |
83,031
-1,142
| -1% | -$306K |
2013 Q2
52 quarters
|
|
406
Everpure Inc
P
$42.2B
| $21.3M | 0.03% |
270,020
+2,758
| +1% | +$202K |
2024 Q2
8 quarters
|
|
407
First Solar
FSLR
$18.7B
| $21.1M | 0.03% |
89,516
-1,490
| -2% | -$349K |
2022 Q4
14 quarters
|
|
408
Credicorp
BAP
$31B
| $20.9M | 0.03% |
53,633
+1,527
| +3% | +$522K |
2013 Q2
52 quarters
|
|
409
Grab
GRAB
$11.8B
| $20.8M | 0.03% |
5,519,350
-18,885
| -0.3% | -$68.8K |
2022 Q1
17 quarters
|
|
410
Darden Restaurants
DRI
$24.7B
| $20.7M | 0.03% |
100,479
-407
| -0.4% | -$81.5K |
2013 Q2
52 quarters
|
|
411
C.H. Robinson
CHRW
$16.4B
| $20.7M | 0.03% |
109,856
+5,250
| +5% | +$933K |
2013 Q2
52 quarters
|
|
412
Verisk Analytics
VRSK
$24.8B
| $20.7M | 0.03% |
115,172
-5,612
| -5% | -$988K |
2013 Q2
52 quarters
|
|
413
Markel Group
MKL
$23.3B
| $20.5M | 0.03% |
10,491
+53
| +0.5% | +$99K |
2013 Q2
52 quarters
|
|
414
Principal Financial Group
PFG
$23.1B
| $20.5M | 0.03% |
190,079
-2,748
| -1% | -$279K |
2013 Q2
52 quarters
|
|
415
Quest Diagnostics
DGX
$26.2B
| $20.4M | 0.03% |
96,148
-1,136
| -1% | -$223K |
2013 Q2
52 quarters
|
|
416
MasTec
MTZ
$15B
| $20.3M | 0.03% |
+48,775
| New | +$18.6M |
2026 Q2
0 quarters
|
|
417
Vivmark Residential
VMRK
$47.9B
| $20.3M | 0.03% |
298,663
+1,793
| +0.6% | +$116K |
2013 Q2
52 quarters
|
|
418
DexCom
DXCM
$32.4B
| $20.2M | 0.03% |
299,649
-25,821
| -8% | -$1.72M |
2019 Q1
29 quarters
|
|
419
Labcorp
LH
$26.2B
| $20.1M | 0.03% |
71,939
-128
| -0.2% | -$33.6K |
2013 Q2
52 quarters
|
|
420
Royalty Pharma
RPRX
$27.7B
| $20.1M | 0.03% |
359,125
+35,302
| +11% | +$1.84M |
2020 Q4
22 quarters
|
|
421
Strategy Inc
MSTR
$60.4B
| $19.9M | 0.03% |
229,471
+1,178
| +0.5% | +$171K |
2024 Q2
8 quarters
|
|
422
Casey's General Stores
CASY
$25.3B
| $19.9M | 0.03% |
25,077
+23,831
| +1,913% | +$19.2M |
2026 Q1
1 quarter
|
|
423
Ares Management
ARES
$26.4B
| $19.9M | 0.03% |
178,955
+16,896
| +10% | +$2.03M |
2022 Q4
14 quarters
|
|
424
Steris
STE
$22B
| $19.8M | 0.03% |
93,823
+7,818
| +9% | +$1.68M |
2019 Q3
27 quarters
|
|
425
CoreWeave
CRWV
$34.3B
| $19.6M | 0.03% |
197,304
-1,656
| -0.8% | -$179K |
2025 Q4
2 quarters
|
|
Similar funds
Aviva's Q2 2026 Portfolio in Review
As of Q2 2026, Aviva held 913 positions worth $67.9B, up 14% from $59.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Aviva's Q2 2026 filing shows 70 new, 471 increased, 285 reduced and 59 closed positions. Its largest new stake was SpaceX: 459,014 shares worth $78.4M. The largest sale was NVIDIA, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2026 buy was SpaceX: 459,014 shares worth $78.4M.
- Aviva added most to Advanced Micro Devices in Q2 2026, an estimated $73.8M increase.
- Aviva's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
- Aviva fully exited Coterra Energy in Q2 2026, selling an estimated $22M.
- Aviva's ten largest holdings make up 34% of its $67.9B portfolio in Q2 2026.
- Aviva opened 70 new positions and closed 59 in Q2 2026.
- Aviva's portfolio value rose 14% quarter-over-quarter to $67.9B.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.